BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30585592)

  • 41. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Review of changes introduced by the new WHO classification (4th edition) of myeloid neoplasms. An overview].
    Komatsu N
    Rinsho Ketsueki; 2009 Mar; 50(3):127-33. PubMed ID: 19352078
    [No Abstract]   [Full Text] [Related]  

  • 43. [Diagnosis of myeloid hematologic malignancies: contributions of the 2001 World Health Organization (WHO) classification].
    Leymarie V; Galoisy AC; Falkenrodt A; Lessard M
    Ann Biol Clin (Paris); 2004; 62(5):513-20. PubMed ID: 15355801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms.
    Patel U; Luthra R; Medeiros LJ; Patel KP
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S62-S74. PubMed ID: 28760304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Myelodysplastic syndrome classification].
    Ghariani I; Braham N; Hassine M; Kortas M
    Ann Biol Clin (Paris); 2013; 71(2):139-44. PubMed ID: 23587576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia.
    Chung A; Hou Y; Ohgami RS; Von Gehr A; Fisk DG; Roskin KM; Li X; Gojenola L; Bangs CD; Arber DA; Fire AZ; Cherry AM; Zehnder JL; Gotlib J; Merker JD
    Cancer Genet; 2017 Oct; 216-217():10-15. PubMed ID: 29025582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.
    Steensma DP
    J Mol Diagn; 2006 Sep; 8(4):397-411; quiz 526. PubMed ID: 16931578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1.
    Vega F; Medeiros LJ; Bueso-Ramos CE; Arboleda P; Miranda RN
    Am J Clin Pathol; 2015 Sep; 144(3):377-92. PubMed ID: 26276769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnostic principles and upcoming updates.
    Geyer JT; Orazi A
    Int J Lab Hematol; 2016 May; 38 Suppl 1():12-9. PubMed ID: 27161873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The myelodysplastic syndromes and myeloproliferative disorders.
    Williams JL
    Clin Lab Sci; 2004; 17(4):223-34. PubMed ID: 15559729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eosinophilic myeloid disorders.
    Noel P
    Semin Hematol; 2012 Apr; 49(2):120-7. PubMed ID: 22449622
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
    Michaux JL; Martiat P
    Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.
    Savage N; George TI; Gotlib J
    Int J Lab Hematol; 2013 Oct; 35(5):491-500. PubMed ID: 23489324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unusual infant eosinophilia: myeloid neoplasm with FGFR1 abnormality.
    Li W; Cooley LD
    Blood; 2016 Sep; 128(10):1440. PubMed ID: 27769039
    [No Abstract]   [Full Text] [Related]  

  • 55. Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias).
    Hasserjian RP; Kelley TW; Weinberg OK; Morgan EA; Fend F
    Am J Clin Pathol; 2019 Aug; 152(3):302-321. PubMed ID: 31263893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood.
    Lasky J; Sakamoto KM
    MedGenMed; 2005 Mar; 7(1):21. PubMed ID: 16369326
    [No Abstract]   [Full Text] [Related]  

  • 57. Changes in the Updated 2016: WHO Classification of the Myelodysplastic Syndromes and Related Myeloid Neoplasms.
    Bennett JM
    Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):607-609. PubMed ID: 27693133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes.
    Tiu RV; Sekeres MA
    Curr Opin Hematol; 2014 Mar; 21(2):131-40. PubMed ID: 24378705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Myelodysplastic syndromes--from FAB to WHO classification].
    Kotlarek-Haus S; Haus O
    Pol Arch Med Wewn; 2005 Nov; 114(5):1128-37. PubMed ID: 16789514
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.